단백질 발현 시장 규모, 점유율, 성장 분석, 제품·서비스별, 시스템 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Protein Expression Market Size, Share, Growth Analysis, By Product and Service, By System Type, By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드:1588499
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 11월
페이지 정보:영문 209 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 단백질 발현 시장 규모는 2022년에 29억 달러로 평가되며, 2023년 32억 9,000만 달러에서 2031년에는 89억 2,000만 달러로 성장하며, 예측 기간(2024-2031년)의 CAGR은 13.3%로 성장할 전망입니다.
단백질 발현 시장은 바이오테크놀러지의 발전에 힘입어 치료용 재조합 단백질에 대한 수요가 증가함에 따라 빠르게 성장하고 있습니다. 맞춤형 의료의 부상으로 맞춤형 단백질 기반 치료에 대한 수요가 더욱 가속화되고 있습니다. 단백질 엔지니어링 및 재조합 단백질의 인공 생산에 대한 지속적인 연구개발이 시장의 발전을 촉진하고 있습니다. 또한 단백질 발현의 기술 혁신은 맞춤형 치료를 통해 환자 치료를 개선할 수 있는 새로운 기회를 열어주고 있습니다. 백혈구 바이러스 및 일시적 발현 시스템을 포함한 첨단 기술 개발은 시장 기업과 학술기관과의 전략적 제휴를 통해 촉진되어 시장 확대를 촉진하고 있습니다.
목차
서론
조사의 목적
정의
시장 범위
조사 방법
정보 조달
2차 데이터 소스와 1차 데이터 소스
시장 규모 예측
시장의 상정과 제한
개요
시장 개요 전망
공급 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 역학
촉진요인
기회
억제요인
과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장의 에코시스템
가격 분석
기술 분석
특허 분석
밸류체인 분석
공급망 분석
고객과 구매 기준 분석
규제 분석
단백질 발현 시장 : 제품·서비스별
시장 개요
시약
발현 벡터
컴피턴트 셀
기기
서비스
단백질 발현 시장 : 시스템 유형별
시장 개요
포유류 세포 발현 시스템
차이니즈 햄스터 난소 세포 시스템(Cho 세포 시스템)
인간 태아 신장 세포 시스템(Hek 293 세포 시스템)
기타 포유류 세포계
원핵생물 발현 시스템
대장균 시스템
기타 원핵생물 발현 시스템
곤충 세포 발현 시스템
바큘로바이러스 시스템
기타 곤충 세포 시스템
효모 발현 시스템
Pichia Systems
Saccharomyces Systems
기타 효모 발현 시스템
무세포 발현 시스템
조류 기반 발현 시스템
단백질 발현 시장 : 용도별
시장 개요
치료 용도
연구 용도
산업 용도
단백질 발현 시장 : 최종사용자별
시장 개요
제약·바이오테크놀러지 기업
학술연구기관
수탁 연구기관 및 수탁 개발 제조 기관(CROS 및 CDMO)
기타 최종사용자
단백질 발현 시장 : 지역별
시장 개요
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카(MEA)
GCC 국가
남아프리카공화국
기타 중동 및 아프리카 지역
경쟁 구도
상위 5사의 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
시장에서의 최근 활동
주요 기업의 시장 점유율(2023년)
주요 기업 개요
Thermo Fisher Scientific, Inc.(US)
Merck KGaA(Germany)
Genscript Biotech Corporation(China)
Agilent Technologies Inc.(US)
Takara Bio, Inc.(Japan)
Bio-Rad Laboratories, Inc.(US)
Qiagen N.V.(Netherlands)
Charles River Laboratories International, Inc.(US)
Danaher Corporation(US)
Sartorius AG(Germany)
Corning Incorporated(US)
Fujifilm Irvine Scientific, Inc.(Acquired by Fujifilm Holdings Corporation)(US)
Lonza Group AG(Switzerland)
Bioneer Corporation(South Korea)
Promega Corporation(US)
Oxford Expression Technologies Ltd.(UK)
Proteogenix(France)
Abeomics Inc.(US)
New England Biolabs, Inc.(US)
Promab Biotechnologies(US)
Sino Biological, Inc.(China)
Jena Bioscience(Germany)
Lifesensors, Inc.(US)
Leading Biology, Inc.(US)
Peak Proteins(UK)
KSA
영문 목차
영문목차
Global Protein Expression Market size was valued at USD 2.90 billion in 2022 and is poised to grow from USD 3.29 billion in 2023 to USD 8.92 billion by 2031, growing at a CAGR of 13.3% in the forecast period (2024-2031).
The protein expression market is experiencing rapid growth due to the increasing demand for recombinant proteins in therapeutic applications, fueled by advancements in biotechnology. The rise of personalized medicine has further accelerated the need for customized protein-based therapies. Ongoing research and development in protein engineering and the artificial production of recombinant proteins are driving market progress. Additionally, technological innovations in protein expression are opening new opportunities to improve patient care through personalized treatments. Strategic collaborations between market players and academic institutions are fostering the development of cutting-edge technologies, including baculovirus and transient expression systems, boosting market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Expression market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Protein Expression Market Segmental Analysis
Global Protein Expression Market is segmented on the product & service, system type, application, end user, and region. By product and service, the market is segmented into Reagents, Expression Vectors, Competent Cells, Instruments, and Services. By system type, the market is segmented into Mammalian Cell Expression Systems, Prokaryotic Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, and Algal-Based Expression Systems. By application, the market is segmented into Therapeutic Applications, Research Applications, and Industrial Applications. By end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations & Contract Development and Manufacturing Organizations (CROs & CDMOs), and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Protein Expression Market
The protein expression market is experiencing significant growth, driven by the widespread use of E. coli bacteria for large-scale protein manufacturing. E. coli is the most commonly used expression host due to its well-established genomic and sequencing systems, which streamline cloning processes. This makes E. coli the preferred choice in the pharmaceutical sector for protein expression. Additionally, this method enhances the strength of binding in the promoter region, optimizing transcription and further boosting its adoption. These factors collectively contribute to the rapid expansion of the protein expression market.
Restraints in the Global Protein Expression Market
The Protein Expression market faces significant barriers to entry, particularly for new organizations. High costs associated with protein expression reagents and products are inhibiting market growth, while limited awareness of relevant diseases further discourages investment. This issue is especially prominent in developing countries and for smaller companies with constrained budgets. Additionally, the lack of supportive insurance systems in emerging economies is restricting the adoption of advanced eukaryotic expression system products. These challenges are hindering the market's expansion and preventing many potential players from entering the space.
Market Trends of the Global Protein Expression Market
The Protein Expression market is experiencing significant growth driven by the rising demand for biologics used in treating chronic diseases such as cancer, autoimmune disorders, and other serious conditions. Biologics, which include vaccines, blood components, modified medicinal proteins, antibodies, pegylated proteins, hormones, and enzymes, are essential in protein translation. As these biologic therapies continue to expand in demand, the need for protein expression products and services is growing, further propelling the market's development. This trend highlights the crucial role of protein translation in the creation and delivery of innovative biologic treatments.
Table of Contents
Introduction
Objectives of the Study
Definitions
Market Scope
Research Methodology
Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
Key Market Insights
Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
Technology Analysis
Patent Analysis
Value Chain Analysis
Supply Chain Analysis
Customer & Buying Criteria Analysis
Regulatory Analysis
Protein Expression Market, By Product & Service
Market Overview
Reagents
Expression Vectors
Competent Cells
Instruments
Services
Protein Expression Market, By System Type
Market Overview
Mammalian Cell Expression Systems
Chinese Hamster Ovary Cell Systems (Cho Cell Systems)
Human Embryonic Kidney Cell Systems (Hek 293 Cell Systems)
Other Mammalian Cell Systems
Prokaryotic Expression Systems
Escherichia Coli Systems
Other Prokaryotic Expression Systems
Insect Cell Expression Systems
Baculovirus Systems
Other Insect Cell Systems
Yeast Expression Systems
Pichia Systems
Saccharomyces Systems
Other Yeast Expression Systems
Cell-Free Expression Systems
Algal-Based Expression Systems
Protein Expression Market, By Application
Market Overview
Therapeutic Applications
Research Applications
Industrial Applications
Protein Expression Market, By End User
Market Overview
Pharmaceutical & Biotechnology Companies
Academic Research Institutes
Contract Research Organizations & Contract Development & Manufacturing Organizations (CROS & CDMOs)
Other End Users
Protein Expression Market Size by Region
Market Overview
North America
USA
Canada
Europe
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023
Key Company Profiles
Thermo Fisher Scientific, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck KGaA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Genscript Biotech Corporation (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agilent Technologies Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Takara Bio, Inc. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bio-Rad Laboratories, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Qiagen N.V. (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Charles River Laboratories International, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Danaher Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sartorius AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Corning Incorporated (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Fujifilm Irvine Scientific, Inc. (Acquired by Fujifilm Holdings Corporation) (US)
